Latest filing published 11 Apr 2024 for Hikma Pharmaceuticals PLC.
Insider track record
No signal scores available.
Brian Hoffmann: trading record in brief
Brian Hoffmann discloses dealings in Hikma Pharmaceuticals PLC to RNS (LSE). Between 12 March 2024 and 9 April 2024, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 11 April 2024: a share grant, in Hikma Pharmaceuticals PLC. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Brian Hoffmann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 53,196 sharesOutside a trading venueISIN GB00B0LCW083RNS:5139884-6
- 34,177 shares@ £18.942100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5103062-4
2 of 2 declarations